glp 1 drugs how long have they been around Frontiers GLP-1: Genetic Variants Related to
Description
This approach isn't suitable for everyone, particularly those with diabetes on insulin or sulfonylureas, pregnant or breastfeeding women, people with a history of eating disorders, those with kidney disease, or frail individuals

Full credit for the original reporting belongs to ET Pharma

This might be a result of decreased amylin sensitivity following prolonged hyperamylinaemia, but there is currently no evidence of this in humans

10.2337/db09-1694 [DOI] [PMC free article] [PubMed] [Google Scholar] 189.Ku HC, Chen WP, Su MJ

Taking the injection on Monday means hunger returns by Friday

Clinical trial results with oral and subcutaneous semaglutide revealed analogous properties, albeit different in magnitude